Cargando…

Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells

Many tumors maintain chromosome-ends through a telomerase-independent, DNA-templated mechanism called alternative lengthening of telomeres (ALT). While ALT occurs in only a subset of tumors, it is strongly associated with mutations in the genes ATRX and DAXX, which encode components of an H3.3 histo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yost, Kathryn E., Clatterbuck Soper, Sarah F., Walker, Robert L., Pineda, Marbin A., Zhu, Yuelin J., Ester, Corbin D., Showman, Soyeon, Roschke, Anna V., Waterfall, Joshua J., Meltzer, Paul S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418139/ https://www.ncbi.nlm.nih.gov/pubmed/30872698 http://dx.doi.org/10.1038/s41598-019-41058-8

Ejemplares similares

ATRX/DAXX: Guarding the Genome against the Hazards of ALT
por: Clatterbuck Soper, Sarah F., et al.
Publicado: (2023)

Switch telomerase to ALT mechanism by inducing telomeric DNA damages and dysfunction of ATRX and DAXX
por: Hu, Yang, et al.
Publicado: (2016)

Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation?
por: Marinoni, Ilaria
Publicado: (2022)

G-quadruplex Stabilization Fuels the ALT Pathway in ALT-positive Osteosarcoma Cells
por: Amato, Roberta, et al.
Publicado: (2020)

Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT)
por: Falcinelli, Marta, et al.
Publicado: (2023)

PML/TRIM19-Dependent Inhibition of Retroviral Reverse-Transcription by Daxx
por: Dutrieux, Jacques, et al.
Publicado: (2015)

High prevalence of MAP2K1 mutations in variant and IGHV4-34 expressing hairy-cell leukemia
por: Waterfall, Joshua J., et al.
Publicado: (2013)

Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size
por: Hackeng, Wenzel M, et al.
Publicado: (2022)

Daxx Inhibits HIV-1 Reverse Transcription and Uncoating in a SUMO-Dependent Manner
por: Maillet, Sarah, et al.
Publicado: (2020)

Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer
por: Bilke, Sven, et al.
Publicado: (2013)

Identification of a novel gene fusion in ALT positive osteosarcoma
por: Mason-Osann, Emily, et al.
Publicado: (2018)

Structural basis for DAXX interaction with ATRX
por: Wang, Xiaoman, et al.
Publicado: (2017)

Effects of BRCA2 deficiency on telomere recombination in non-ALT and ALT cells
por: Sapir, Ester, et al.
Publicado: (2011)

Structural and biochemical characterization of DAXX-ATRX interaction
por: Li, Zhuang, et al.
Publicado: (2017)

DAXX in cancer: phenomena, processes, mechanisms and regulation
por: Mahmud, Iqbal, et al.
Publicado: (2019)

miR-23a impairs bone differentiation in osteosarcoma via down-regulation of GJA1
por: Gindin, Yevgeniy, et al.
Publicado: (2015)

DAXX drives de novo lipogenesis and contributes to tumorigenesis
por: Mahmud, Iqbal, et al.
Publicado: (2023)

Whole Genome Sequencing of Newly Established Pancreatic Cancer Lines Identifies Novel Somatic Mutation (c.2587G>A) in Axon Guidance Receptor Plexin A1 as Enhancer of Proliferation and Invasion
por: Sorber, Rebecca, et al.
Publicado: (2016)

Regulation of mitosis and taxane response by Daxx and Rassf1
por: Giovinazzi, Serena, et al.
Publicado: (2011)

Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX
por: de Nonneville, Alexandre, et al.
Publicado: (2021)

The histone chaperone function of Daxx is dispensable for embryonic development
por: Sun, Chang, et al.
Publicado: (2023)

Tumor suppressor protein Pdcd4 interacts with Daxx and modulates the stability of Daxx and the Hipk2-dependent phosphorylation of p53 at serine 46
por: Kumar, N, et al.
Publicado: (2013)

FUS inclusions disrupt RNA localization by sequestering kinesin-1 and inhibiting microtubule detyrosination
por: Yasuda, Kyota, et al.
Publicado: (2017)

A role for the histone chaperone DAXX in the structural organization of heterochromatin
por: Rapkin, Lindsy M, et al.
Publicado: (2013)

The PML-Interacting Protein DAXX: Histone Loading Gets into the Picture
por: Salomoni, Paolo
Publicado: (2013)

The histone chaperone DAXX maintains the structural organization of heterochromatin domains
por: Rapkin, Lindsy M., et al.
Publicado: (2015)

The Clinical Implications of Death Domain-Associated Protein (DAXX) Expression
por: Ko, Taek Yong, et al.
Publicado: (2018)

Stitched peptides as potential cell permeable inhibitors of oncogenic DAXX protein
por: Jelinska, Clare, et al.
Publicado: (2023)

Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumours
por: Pipinikas, Christodoulos P, et al.
Publicado: (2015)

TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT
por: de Nonneville, Alexandre, et al.
Publicado: (2022)

Structural and mechanistic insights into ATRX-dependent and -independent functions of the histone chaperone DAXX
por: Hoelper, Dominik, et al.
Publicado: (2017)

DAXX interacts with phage ΦC31 integrase and inhibits recombination
por: Chen, Jin-zhong, et al.
Publicado: (2006)

Berberine represses DAXX gene transcription and induces cancer cell apoptosis
por: Li, Jiansha, et al.
Publicado: (2013)

Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma
por: Zizzi, Antonio, et al.
Publicado: (2013)

Prognostic significance of Daxx NCR (Nuclear/Cytoplasmic Ratio) in gastric cancer
por: Xu, Jian‐feng, et al.
Publicado: (2017)

Daxx maintains endogenous retroviral silencing and restricts cellular plasticity in vivo
por: Wasylishen, Amanda R., et al.
Publicado: (2020)

DAXX inhibits cancer stemness and epithelial–mesenchymal transition in gastric cancer
por: Wu, Chaofan, et al.
Publicado: (2020)

Formal reply to “Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX”
por: Feuerbach, Lars
Publicado: (2021)

H3.Y discriminates between HIRA and DAXX chaperone complexes and reveals unexpected insights into human DAXX-H3.3-H4 binding and deposition requirements
por: Zink, Lisa-Maria, et al.
Publicado: (2017)

Galerie Alte Meister /
Publicado: (1979)

Cannot write session to /tmp/vufind_sessions/sess_uc9eohfarg8ca58uc2fn89ml5q